PIN61 Cost of Virologic Response with Two Active Drugs in the Optimized Background Therapy with Etravirine, Raltegravir, and Maraviroc in the Brazilian National AIDS Program
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.247
https://www.valueinhealthjournal.com/article/S1098-3015(11)01809-2/fulltext
Title :
PIN61 Cost of Virologic Response with Two Active Drugs in the Optimized Background Therapy with Etravirine, Raltegravir, and Maraviroc in the Brazilian National AIDS Program
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01809-2&doi=10.1016/j.jval.2011.08.247
First page :
A276
Section Title :
Infection
Open access? :
No
Section Order :
227